Kirby Seminar - Ceclia Moore - Health outcomes in gay men: the HIM and pH data linkage study

Event date
Tuesday 24th February 2015
Event time
1:00 PM
Event address
The Kirby Institute Level 6 Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052

Location:

The Kirby Institute Level 6 Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052

Open to

All

Contact for enquiries 

Rata Joseph +61 (0)2 9385 0900 rjoseph@kirby.unsw.edu.au

The Kirby Institute is pleased to present:

Ceclia Moore - Health outcomes in gay men: the HIM and pH data linkage study

Tuesday 24th February 2015
1pm - 2pm

Abstract:  Attention to gay men’s health was heightened by the  advent of the HIV/AIDS epidemic, firstly as a key population identified as being at risk of infection and then as a major force in the HIV/AIDS response. Gay men continue to shoulder a disproportionate amount of HIV disease burden in high income countries including Australia. While only around 1.6% of Australian males identify as gay or homosexual, they make up 88% of people with diagnosed new HIV infection. Despite attention to gay men’s health in relation to HIV transmission, acquisition, infection and disease progression, there is a dearth of systematically collected and detailed information on the long term health of gay men. From the available information on gay men’s health related behaviour, there are indications that gay men could be at risk for worse health outcomes compared with the general population.
 
This presentation will present the background, methods and some early results of a record linkage study examining morbidity and mortality in two cohorts of HIV negative and positive gay and bisexual men.

Biography: Cecilia joined the biostatistics and database program in 2012 as a biostatistician and subsequently enrolled in a PhD degree under the supervision of Dr Janaki Amin. Prior to working at the Kirby Institute, she received a Bachelor of Science and a Masters in International Public Health from the University of Sydney. Her work is primarily involved in the design and analysis of clinical trials and data linkage studies.